(Maybe) I Can See More Clearly Now: FDA Issues Q&A Guidance on DTC Rx Ads | Arnall Golden Gregory LLP

On December 26, 2023, the Food and Drug Administration’s Office of Prescription Drug Promotion (“OPDP”) issued a Questions and Answers Guidance for industry titled “Direct-to-Consumer...

Related Keywords

,Promotional Labeling Branch ,Drug Administration Office Of Prescription Promotion ,Drug Administration ,Prescription Drug Promotion ,Answers Guidance ,Consumer Prescription Drug Advertisements ,Major Statement ,Neutral Manner ,Radio Format Final Rule Questions ,Radio Format ,November Final Rule ,Final Rule ,Drug Evaluation ,Biologics Evaluation ,Untitled Letters ,Warning Letters ,Untitled Letter ,